Key Financial Data Of Reporting Company

Fuji Pharma Co.,Ltd. - Filing #7264782

Concept 2024-10-01 to
2025-03-31
As at
2025-03-31
As at
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-03-31
As at
2024-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
24,095,000,000 JPY
46,138,000,000 JPY
21,388,000,000 JPY
Ordinary profit (loss)
2,209,000,000 JPY
4,445,000,000 JPY
2,165,000,000 JPY
Net assets
45,734,000,000 JPY
45,563,000,000 JPY
44,066,000,000 JPY
Total assets
92,672,000,000 JPY
90,000,000,000 JPY
85,006,000,000 JPY
Basic earnings (loss) per share
52.83
252.85
175.15
Diluted earnings per share
Equity-to-asset ratio
0.493 xbrli:pure
0.506 xbrli:pure
0.518 xbrli:pure
Net cash provided by (used in) operating activities
2,131,000,000 JPY
4,151,000,000 JPY
-445,000,000 JPY
Net cash provided by (used in) investing activities
-2,764,000,000 JPY
-1,658,000,000 JPY
1,457,000,000 JPY
Net cash provided by (used in) financing activities
2,750,000,000 JPY
-435,000,000 JPY
-1,998,000,000 JPY
Cash and cash equivalents
6,695,000,000 JPY
4,585,000,000 JPY
1,375,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.